Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas.

OBJECTIVE The objective of our study was to evaluate the feasibility rate and the reasons for infeasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas (HCCs) at planning sonography. MATERIALS AND METHODS We retrospectively evaluated 248 patients who had been referred for planning sonography at our department between October 2005 and February 2006. We reviewed the radiologic reports of 256 planning sonography examinations in terms of the rate of feasible cases and the reasons for infeasibility. The reasons for infeasibility were classified in six categories: an inconspicuous tumor, an inadequate electrode path, an organ vulnerable to collateral thermal damage, a tumor that was too large or too many tumors, and a high risk of the heat sink effect. In addition, we assessed the treatment modality for the patients who were determined to have HCCs for which percutaneous radiofrequency ablation was not feasible. RESULTS In 141 (55%) of the 256 planning sonography examinations, percutaneous radiofrequency ablation was feasible. The remaining 115 (45%) planning sonography examinations revealed that radiofrequency ablation was not a feasible procedure. The reasons for infeasibility included an inconspicuous tumor in 77 patients (55.8%), an inadequate electrode path in 33 patients (23.9%), an organ vulnerable to collateral thermal damage in 14 patients (10.1%), a tumor that was too large or too many tumors in eight patients (5.8%), a high risk of the heat sink effect in five patients (3.6%), and a portal vein thrombosis in one patient (0.7%). One reason for infeasibility was found in 96 patients, two reasons in 19 patients, and four reasons in one patient. Seventy (61.9%) of 113 patients for whom radiofrequency ablation was not feasible underwent transcatheter arterial chemoembolization as an alternative treatment. CONCLUSION In approximately half of the patients for whom percutaneous radiofrequency ablation of HCC is requested, the procedure is not feasible, mainly due to inconspicuous tumors, at planning sonography. Additional objective criteria for assessing the feasibility of radiofrequency ablation and therapeutic strategies according to the reasons for infeasibility should be investigated further.

[1]  Y. Watanabe,et al.  Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  S Nahum Goldberg,et al.  Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[3]  R. Poon,et al.  Treatment strategy to optimize radiofrequency ablation for liver malignancies. , 2006, Journal of vascular and interventional radiology : JVIR.

[4]  S Nahum Goldberg,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria. , 2005, Radiology.

[5]  M. Choi,et al.  Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series , 2007, European Radiology.

[6]  Yi-Cheng Chen,et al.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. , 2004, Gastroenterology.

[7]  T. de Baère,et al.  Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. , 2005, Radiology.

[8]  T. Livraghi,et al.  Radiofrequency Ablation of Liver Tumors: The Role of Microbubble Ultrasound Contrast Agents , 2006, Ultrasound quarterly.

[9]  Cheol Min Park,et al.  Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[10]  Carlo Bartolozzi,et al.  Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. , 2005, Radiology.

[11]  Shinpei Sato,et al.  Percutaneous radiofrequency ablation for hepatocellular carcinoma , 2005, Cancer.

[12]  Luigi Solbiati,et al.  Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. , 2004, European journal of radiology.

[13]  G. Snell,et al.  Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. , 2007, The Annals of thoracic surgery.

[14]  J. Charboneau,et al.  The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. , 2007, Clinical radiology.

[15]  Luigi Solbiati,et al.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. , 2003, Radiology.

[16]  Luc Soler,et al.  Precise determination of regions of interest for hepatic RFA planning , 2007, SPIE Medical Imaging.

[17]  H. Yamagata,et al.  Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system. , 2007, European journal of radiology.

[18]  John Wong,et al.  Learning Curve for Radiofrequency Ablation of Liver Tumors: Prospective Analysis of Initial 100 Patients in a Tertiary Institution , 2004, Annals of surgery.

[19]  T. Kawabe,et al.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. , 2005, Gastroenterology.

[20]  S. Mulier,et al.  Complications of radiofrequency coagulation of liver tumours , 2002, The British journal of surgery.

[21]  R. Fisher,et al.  Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience. , 2007, Transplantation proceedings.

[22]  W. Kwon,et al.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation. , 2009, British Journal of Radiology.

[23]  Y. Hiasa,et al.  Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites , 2007, Journal of Gastroenterology.

[24]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[25]  Carlo Bartolozzi,et al.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. , 2003, Radiology.

[26]  S. Fan,et al.  Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective , 2002, Annals of surgery.

[27]  K. Togashi,et al.  Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. , 2004, Journal of vascular and interventional radiology : JVIR.

[28]  C. Yoon,et al.  Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. , 2009, Journal of vascular and interventional radiology : JVIR.